AbbVie Inc.
ABBV 229.74 (-0.02%) 0.04
Health Care
Biotechnology
Quality Checklist 1/8
Est. EPS Growth > 5%
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $406.04(B)
EV: $469.26(B)
Total Equity: $-2.60(B)
Earnings date: Jan-30-2026
P/E: 172.74
Forward P/E: 21.59
P/FCF: 20.62
P/S: 6.81
P/B: N/A
EPS: $1.3
EPS (fwd): $10.6
FCF/share: $11.1
Revenue/share: $33.7
Book value/share: $-1.5
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Debt/Equity: 48
Current Ratio: 0.70
Gross margin: 71.5%
Operating margin: 24.1%
Net margin: 4.0%
Dividend/share: $6.6
Div. yield: 2.86%
Growth Estimates
Revenue
CAGR: 7.2%FY+1$60.93(B)
FY+2(+9.4%)$66.68(B)
FY+3(+7.7%)$71.83(B)
FY+4(+7.0%)$76.84(B)
FY+5(+4.8%)$80.49(B)
Net Income
CAGR: 14.5%FY+1$18.93(B)
FY+2(+32.7%)$25.12(B)
FY+3(+11.3%)$27.96(B)
FY+4(+9.4%)$30.59(B)
FY+5(+6.4%)$32.56(B)
EPS
CAGR: 15.3%FY+1$10.64
FY+2(+33.9%)$14.25
FY+3(+11.2%)$15.84
FY+4(+10.8%)$17.55
FY+5(+7.3%)$18.83
FCF per share
CAGR: 15.2%FY+1$10.23
FY+2(+43.3%)$14.66
FY+3(+6.2%)$15.57
FY+4(+6.4%)$16.56
FY+5(+8.8%)$18.01